Financials data is unavailable for this security.
View more
Year on year Starpharma Holdings Ltd grew revenues 131.84% from 4.21m to 9.76m while net income improved from a loss of 15.64m to a smaller loss of 8.17m.
Gross margin | 93.52% |
---|---|
Net profit margin | -83.69% |
Operating margin | -83.69% |
Return on assets | -18.37% |
---|---|
Return on equity | -25.95% |
Return on investment | -24.10% |
More ▼
Cash flow in AUDView more
In 2024, cash reserves at Starpharma Holdings Ltd fell by 11.82m. Cash Flow from Investing was negative at 89.00k, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 6.98m for operations while cash used for financing totalled 4.75m.
Cash flow per share | -0.0171 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0682 |
---|---|
Tangible book value per share | 0.0682 |
More ▼
Balance sheet in AUDView more
Current ratio | 4.94 |
---|---|
Quick ratio | 4.58 |
Total debt/total equity | 0.1255 |
---|---|
Total debt/total capital | 0.1115 |
More ▼